ResMed, Inc. (RMD)
258.92
+1.53
(+0.59%)
USD |
NYSE |
Mar 03, 11:12
ResMed Cash from Investing (Quarterly) : -50.94M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -512.00M |
| Abbott Laboratories | -913.00M |
| Baxter International, Inc. | -198.00M |
| Stryker Corp. | -305.00M |
| Globus Medical, Inc. | -111.45M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 339.74M |
| Cash from Financing (Quarterly) | -258.35M |
| Free Cash Flow | 1.777B |
| Free Cash Flow Per Share (Quarterly) | 2.085 |
| Free Cash Flow to Equity (Quarterly) | 303.82M |
| Free Cash Flow to Firm (Quarterly) | 305.19M |
| Free Cash Flow Yield | 4.67% |